Asthma study: BREATHE Intervention
Official title BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
ClinicalTrials.gov ID: NCT05341726
What this study is testing
- What it's testing
- This study is testing whether a new care plan helps control asthma. It also looks at what makes it hard or easy to use this plan in clinics.
- Who it's for
- You may be able to join if you are a Black adult with uncontrolled asthma.
- What's involved
- You would get care at a community health center. The team will check how well your asthma is controlled.
- Time commitment
- The study involves visits to your clinic to track your health.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- (participants): Patients participants will
- be adults (\> or = 18 years of age)
- self-report race as 'Black' race (African American, African, Caribbean, West Indian, multi-racial [Black AND one or more additional races])
- have clinician-diagnosed persistent asthma (defined as being prescribed inhaled corticosteroids in the last 48 months) or have had an asthma...
- receive asthma care at a partner FQHC and
You likely can't join if
- non-English speaking
- serious mental health conditions that preclude completion of study procedures or confound analyses or
- must be identified by patient participant as a loved one and
- non-English speaking or
- serious mental health conditions that preclude completion of study procedures or confound analyses
See the full eligibility criteria
- (participants): Patients participants will
- be adults (\> or = 18 years of age)
- self-report race as 'Black' race (African American, African, Caribbean, West Indian, multi-racial [Black AND one or more additional races]); identify their ethnicity as Hispanic OR non-Hispanic
- have clinician-diagnosed persistent asthma (defined as being prescribed inhaled corticosteroids in the last 48 months) or have had an asthma exacerbation (e.g., ER visit, course of Prednisone) regardless of controller...
- receive asthma care at a partner FQHC and
- screen positive for uncontrolled asthma as measured by the Asthma Control Questionnaire- 6 items (ACQ-6) and erroneous beliefs as measured by the Conventional and Alternative Management for Asthma (CAM-A) survey.
- non-English speaking
- serious mental health conditions that preclude completion of study procedures or confound analyses or
- must be identified by patient participant as a loved one and
- non-English speaking or
- serious mental health conditions that preclude completion of study procedures or confound analyses
The study team makes the final eligibility decision.
Where it is enrolling
- Beacon, New York, United States
- Brooklyn, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Beacon, New York, United States; Brooklyn, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.